Overview

Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis

Status:
Unknown status
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
An open-label study to evaluate the efficacy and safety of orally administered Tamibarotene to patients of Lupus Nephritis
Phase:
Phase 2
Details
Lead Sponsor:
Kinki University